NTrans Technologies
Utrecht · Founded 2015
About NTrans Technologies
NTrans Technologies offers a proprietary platform technology for the intracellular delivery of bioactive molecules. The company is further developing this technology for both research and clinical purposes as a method for the delivery of biologicals that is safe, non-toxic, highly efficient, and easy to use. NTrans Technologies' goal is to be a leader in technologies for the transduction of proteins and other bioactive molecules into primary cells.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Last round: Series Unknown (Jan 2017)
- Website: https://www.ntranstechnologies.com/
- Phone: +31 (0)644448450
Industries & Categories
Biotechnology, Product Research, Wellness
Social Profiles
Canonical: https://fsome.com/organization/ntrans-technologies-120931 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.